跳至主要内容
临床试验/ACTRN12611000984998
ACTRN12611000984998已完成未知

In patients undergoing hip arthroscopy, how would platelet rich plasma, compared with placebo, improve post operative outcome in the short and long term.

Dr. Omer Mei-Dan0 个研究点目标入组 105 人开始时间: 2011年9月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 50 Years(—)
性别
All

入选标准

  • 1. healthy patients undergoing hip Arthroscopy due to FAI
  • 2. Ages 16-50
  • 3. No OA changes according to XR and surgery observation
  • 4. No previous hip surgery
  • 5. No other influential disabilities in lower limbs 6. No chronic use of NSAID, steroids or chemotherapy drugs

排除标准

  • Non-ambulating patients, those with severe advanced osteoarthritic changes on radiological imaging, patients with suspected previous joint infection, pregnant or lactating women, open wounds or skin ulcers and those taking anticoagulants or having a prolonged bleeding time were excluded.

研究者

发起方
Dr. Omer Mei-Dan

相似试验